Immunome (NASDAQ:IMNM) Stock Price Up 4.4% After Insider Buying Activity
Immunome, Inc. (NASDAQ:IMNM – Get Free Report)’s share price traded up 4.4% on Thursday after an insider bought additional shares in the company. The stock traded as high as $7.68 and last traded at ...
Business Weekly4 天
Brainomix eyes US growth after $18m Series C round
Brainomix, an Oxford-born company pioneering AI-powered imaging tools in stroke and lung fibrosis, has clinched an $18 ...
Aura Biosciences’ (AURA) Buy Rating Reaffirmed at HC Wainwright
Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a ...
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an ...
Guggenheim Remains a Buy on Eledon Pharmaceuticals (ELDN)
In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on Eledon Pharmaceuticals (ELDN – Research Report), with a ...
Stifel Nicolaus Keeps Their Buy Rating on Pyxis Oncology (PYXS)
In a report released on March 21, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with ...